About usSign in
Status
ACTIVE
Global HQ
San Francisco, United States
Countries of investment
  • USA
  • France
Investment stages
  • Pre-Seed
  • Seed
Industries
  • Fintech
  • AI
  • Health Tech
  • Internet
About
Cambridge Capital Group, headquartered in Cambridge, United Kingdom, has been a leading business angel group since 2001. They consist of over 80 investors, including private investors, family offices, and venture funds, who have invested more than £30M in over 100 hitech startups within the UK's Golden Triangle. The group focuses on seed, startup, and early growth opportunities, and invests in several sectors, including LegalTech, Robotics, Cybersecurity, and Biotech. Notable exits include the sale of Swiftkey to Microsoft for $250 million. CCG is recognized for its thorough investment philosophy and a strong track record of successful exits and high financial returns for its members.
Min check size
$150K
Max check size
-
Fund size
NPS

Investment Thesis

Cambridge Capital Group focuses on investing in early stage Technology startups primarily based within the UK's Golden Triangle. Their aim is to back innovative and high potential hitech businesses.
Lead investor
Co Invest
Number of exits
Preferred contact method

Portfolio

Cytochroma

Porotech

Qualus

Cambridge GaN Devices

Boutros Bear

Porotech

Lightpoint Medical

Obrizum

Sorex Sensors

Ablatus Therapeutics

Fund number
Vintage Year
Net Internal Rate of Return
Investment Multiple
Capital Allocation
Management Fee
Carried Interest
AUM
Follow-on Investments
Graduation Rate
Write-Off Ratio
Last profile update timestamp